Abstract
The authors present an uncommon complication of pediatric anterior cruciate ligament (ACL) reconstruction involving a rare organism in the setting of multiple patient-specific factors that altered treatment. Management of postoperative mycobacterial infections requires thorough knowledge of the side effects of each medication used. Prolonged use of a fluoroquinolone in the setting of ACL reconstruction graft healing introduces the risk of injury to the graft, and tactful patient counseling must be employed to help diminish this risk. The potential for ototoxicity secondary to extended aminoglycoside use is especially worrisome and should be monitored. This plan required careful balancing of several important considerations, and the patient was successfully treated while achieving a good clinical outcome.
Recommended Citation
Warren, Daniel; David Michaeli; Benjamin Estrada; and James Slauterbeck. "Treatment of an Unusual Infection Following Anterior Cruciate Ligament Reconstruction." Western Journal of Orthopaedics 12, 1 (2023). https://digitalrepository.unm.edu/wjo/vol12/iss1/6